RecruitingNot ApplicableNCT05756959

Myopia Control Combined PBM With Myopic Defocus Lens in Children

Myopia Control Combined PBM With Myopic Defocus Lens in Children: Double-blind RCT for 6 Month


Sponsor

Beijing Airdoc Technology Co., Ltd.

Enrollment

304 participants

Start Date

Dec 12, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.


Eligibility

Min Age: 6 YearsMax Age: 13 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called PBM, a medical device called Peripheral defocus spectacles, and others for people with myopia, progressive. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 13 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPBM

PBM, is a low intensity red light at wavelength of 650nm; Peripheral defocus spectacels is a peripheral design glasseses for correct myopia and control myopia

DEVICEPeripheral defocus spectacles

plus power design of many peripheral small lenses to achieve myopic defocus of the retina in the peripheral retina

DEVICESingle vision spectacles

Distance vision correction with the single vision spectacles for the myopia correction methods (glasseses for myopia correction)


Locations(1)

the first people's hospital of Xuzhou

Xuzhou, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05756959


Related Trials